Clinical trial

Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After…

NCT00151632 · Rennes University Hospital, Other · Terminated

Key facts

NCT number NCT00151632
Title Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation
Official title Evaluation of the Benefit/Risk Ratio of a Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil on the Prevention of Complications in Adult Liver Transplantation
Acronym MMF-FK
Lead sponsor Rennes University Hospital, Other
Collaborators Ministry of Health, France
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Evidence of Liver Transplantation
Intervention type Drug
Interventions Mycophenolate mofetil, Tacrolimus
Enrollment 195
Start date May 1, 2003
Primary completion Dec 1, 2008
Completion May 1, 2009
First posted Sep 9, 2005
Last update posted Jul 4, 2012
Countries France

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies